Co-Authors
This is a "connection" page, showing publications co-authored by Simon Tiberi and Adam Zumla.
Connection Strength
0.514
-
Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S96-S99.
Score: 0.233
-
COVID-19 and tuberculosis-threats and opportunities. Int J Tuberc Lung Dis. 2020 08 01; 24(8):757-760.
Score: 0.224
-
Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials. Am J Trop Med Hyg. 2020 09; 103(3):960-964.
Score: 0.056